Steris | STE - Fremdkapital





Fremdkapital Veränderung Datum
3M USD 10.91B 26M 2026-03
Accuray USD 124.78M 2.54M 2025-12
Avanos Medical USD 87.3M 3M 2026-03
Baxter International USD 8.62B 852M 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Boston Scientific USD 11.01B 19M 2025-12
CONMED USD 834.23M 18.78M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.3B 54.4M 2026-03
Ecolab USD 6.92B 443.4M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Fortive USD 2.59B 282.8M 2026-03
Getinge SEK 8.92B 640M 2025-12
Globus Medical USD 436K 9K 2025-12
Haemonetics USD 1.22B 299.58M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Inogen USD 0 0 2022-06
Insulet USD 929.5M 1.3M 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Masimo USD 445.7M 72.3M 2026-03
Olympus JPY 159.7B 61M 2026-03
Orthofix International USD 221.33M 46.88M 2026-03
Owens Minor USD 1.8B 35.38M 2025-12
ResMed USD 404.17M 245K 2026-03
Steris USD 1.81B 85.6M 2026-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 601.77M 291.73M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03